Carson Allaria Wealth Management, Ltd. Exact Sciences Corp Transaction History
Carson Allaria Wealth Management, Ltd.
- $169 Million
- Q4 2024
A detailed history of Carson Allaria Wealth Management, Ltd. transactions in Exact Sciences Corp stock. As of the latest transaction made, Carson Allaria Wealth Management, Ltd. holds 246 shares of EXAS stock, worth $10,885. This represents 0.01% of its overall portfolio holdings.
Number of Shares
246
Previous 246
-0.0%
Holding current value
$10,885
Previous $16,000
18.75%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding EXAS
# of Institutions
668Shares Held
152MCall Options Held
4.25MPut Options Held
1.89M-
Capital World Investors Los Angeles, CA17.5MShares$776 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA17MShares$753 Million0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$534 Million0.01% of portfolio
-
State Street Corp Boston, MA6.23MShares$276 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.76MShares$255 Million0.04% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $7.83B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...